서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 40 of 68

Issue DateTitle / Author(s) / CitationFileAltmetrics
2007-08
Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naive adults
DOI
2009-08
Preliminary Effects of Oral Uridine on the Ocular Surface in Dry Eye Patients

Chang, Ki Cheol; Oh, Joo Youn; In, Youn Seok; Kim, Mee Kum; Shin, Ki Cheul; Wee, Won Ryang; Lee, Jin Hak; Park, Myung Gyu

Journal of Korean Medical Science, Vol.24 No.4, pp.701-707

DOI
2012-03
Adverse pulmonary reactions associated with the use of monoclonal antibodies in cancer patients
DOI
2013-01
RimabotulinumtoxinB vs. onabotulinumtoxinA for the treatment of forehead lines: An evaluator-blind, randomized, pilot study

Lee, D. H.; Kang, S. M.; Feneran, A.; Youn, C. S.; Kim, J. K.; Cho, S.; Won, C. H.; Chang, S. E.; Lee, M. W.; Choi, J. H.; Moon, K. C.

Journal of the European Academy of Dermatology and Venereology, Vol.27 No.1, pp.e1-e7

DOI
2014-02
Use of Intravenous Fentanyl Against Morphine Tolerance in Breakthrough Cancer Pain: A Case Series and Literature Review

Hwang, In Cheol; Bruera, Eduardo; Park, Sang Min

American Journal of Hospice and Palliative Medicine, Vol.31 No.1, pp.109-111

DOI
2014-08
Development of antirituximab antibodies in children with nephrotic syndrome

Ahn, Yo Han; Kang, Hee Gyung; Lee, Jiwon M.; Choi, Hyun Jin; Ha, Il-Soo; Cheong, Hae Il

Pediatric Nephrology, Vol.29 No.8, pp.1461-1464

DOI
2014-11
Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer
DOI
2014-12
A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley rats
DOI
2015-07
Intravitreally injected anti-VEGF antibody reduces brown fat in neonatal mice
DOI
2015-07
Standardization of the methods and reference materials used to assess virus content in varicella vaccines
DOI
2016-03
Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer: A phase II global study
DOI
2016-06
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
DOI
2016-07
Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non-Small-Cell Lung Cancer
DOI
2016-10
Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit

Han, Ji-Min; Ah, Young-Mi; Suh, Sung Yun; Jung, Sun-Hoi; Hahn, Hyeon Joo; Im, Seock-Ah; Lee, Ju-Yeun

International Journal of Clinical Pharmacy, Vol.38 No.5, pp.1124-1132

DOI
2016-12
Pooled analysis of CNS response to alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung cancer
DOI
2017-05
CONSECUTIVE ANALYSIS OF MUTATION SPECTRUM IN THE DYSTROPHIN GENE OF 507 KOREAN BOYS WITH DUCHENNE/BECKER MUSCULAR DYSTROPHY IN A SINGLE CENTER
DOI
2017-06
Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies
DOI
2017-07
Selection of Binder and Solvent for Solution-Processed All-Solid-State Battery

Lee, Kyulin; Kim, Sangryun; Park, Jesik; Park, Sung Hyeon; Coskun, Ali; Jung, Dae Soo; Cho, Woosuk; Choi, Jang Wook

Journal of the Electrochemical Society, Vol.164 No.9, pp.A2075-A2081

DOI
2017-08
Trends of fall accidents in the us construction industry

Kang, Youngcheol; Siddiqui, Sohaib; Suk, Sung Joon; Chi, Seokho; Kim, Changwan

Journal of Construction Engineering and Management - ASCE, Vol.143 No.8, p. 04017043

DOI
2017-08
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
DOI
2017-09
Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy
DOI
2017-11
PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
DOI
2018-02
Phase I pharmacokinetic study of nivolumab in Korean patients with advanced solid tumors
DOI
2018-02
Early therapeutic drug monitoring of posaconazole oral suspension in patients with hematologic malignancies
DOI
2018-03
Long-term trastuzumab (Herceptin (R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
view fileDOI
2018-03
Phase III, Randomized study of dual human epidermal growth factor receptor 2 (HER2) blockade with lapatinib plus trastuzumab in combination with an aromatase inhibitor in postmenopausal women with HER2-positive, hormone receptor-positive metastatic breast cancer: ALTERNATIVE
DOI
2018-03
Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012
DOI
2018-05
Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia
DOI
2018-08
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
DOI
2018-08
Low-dose nivolumab can be effective in non-small cell lung cancer: Alternative option for financial toxicity
DOI
2018-09
Application of industrial risk management practices to control natural hazards, facilitating risk communication

Lee, Jongook; Lee, Dong Kun

ISPRS International Journal of Geo-Information, Vol.7 No.9, p. 377

DOI
2018-11
Symptom-alleviating effect and adverse effect of dienogest in Korean women with endometriosis

Jeong, Seon Hwa; Lee, Dayong; Kim, Seul Ki; Jee, Byung Chul

Gynecological Endocrinology, Vol.34 No.11, pp.970-974

DOI
2018-12
Measurement of hepatitis B virus DNA in fresh versus processed dentin from chronically infected patients

Um, Inwoong; Choi, Sungweon; Kim, Youngkyun; Pang, Kangmi; Lee, Jongho; Lee, Minsun; Kim, Bongju

Journal of Translational Medicine, Vol.16 No.1, p. 351

DOI
2019-01
Long-Term Effects of In Vivo Genome Editing in the Mouse Retina Using Campylobacter jejuni Cas9 Expressed via Adeno-Associated Virus
DOI
2019-02
T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
DOI
2019-04
Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
DOI
2019-05
Palbociclib plus letrozole as first-line therapy in postmenopausal Asian women with metastatic breast cancer: Results from the phase III, randomized PALOMA-2 study
DOI
2019-06
Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea
view fileDOI
2019-07
Long-Term Comparison of Platinum Chromium Everolimus-Eluting Stent vs. Cobalt Chromium Zotarolimus-Eluting Stent-3-Year Outcomes From the HOST-ASSURE Randomized Clinical Trial -
DOI
2019-07
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
DOI
1 2